Jörg Schröder

Title: Jörg Schröder: Innovator in Medicinal Chemistry

Introduction

Jörg Schröder is a notable inventor based in Schwabenheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating parasitic diseases. With a total of 3 patents to his name, his work has the potential to impact veterinary medicine positively.

Latest Patents

Schröder's latest patents focus on N-heteroaryl compounds with cyclic bridging units. These compounds are designed for the treatment of parasitic diseases, specifically helminth infections. His inventions include medicaments that can be administered to animals suffering from parasitosis. The patents also cover the preparation of these compounds and the development of pharmaceutical compositions and kits that incorporate them.

Career Highlights

Throughout his career, Jörg Schröder has worked with prominent companies in the pharmaceutical industry, including Intervet Inc. and Intervet International B.V. His experience in these organizations has allowed him to refine his expertise in developing effective treatments for animal health.

Collaborations

Schröder has collaborated with several professionals in his field, including Michael Berger and Christopher Kern. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Jörg Schröder's innovative work in the field of medicinal chemistry highlights his commitment to improving animal health through effective treatments. His contributions, particularly in the area of N-heteroaryl compounds, demonstrate the importance of research and development in combating parasitic diseases.